SCIENCE 37

Resources

 

All the clinical research insights you need, from our world-class experts.

SCIENCE 37

Resources

 

All the clinical research insights you need, from our world-class experts.

Blog
Treated Like a Human, Not a Statistic
Treated Like a Human, Not a Statistic
Virtual clinical trial access program provided breast cancer patients with personal, in-home treatment during the COVID-19 pandemic.
Read Now
/treated-human-not-statistic
Case Study
The Science 37 Metasite in Action: How Science 37 Accelerated Enrollment for a Dermatology Trial.
The Science 37 Metasite in Action: How Science 37 Accelerated Enrollment for a Dermatology Trial.
A biopharma company was conducting a Phase II randomized controlled trial in the United States for a dermatological condition. The protocol required patients aged 18 or older with mild…
Learn More
/Resources/science-37-metasite-action-how-science-37-accelerated-enrollment-dermatology-trial
Factsheet
The Science 37 Metasite™
The Science 37 Metasite™
Science 37's mission is to accelerate clinical research by enabling universal trial access for patients. As a single Metasite, we reach an expanded patient population beyond the…
Learn More
/Resources/science-37-metasitetm
Case Study
Decentralized in Action: How Science 37 Accelerated Enrollment for a Diagnostic Oncology Trial.
Decentralized in Action: How Science 37 Accelerated Enrollment for a Diagnostic Oncology Trial.
A biopharma company was investigating how its diagnostic screening technology—a one-time blood sample—performed against the gold standard cancer screening procedure. Download to learn…
Read More
/Resources/decentralized-action-how-science-37-accelerated-enrollment-diagnostic-oncology-trial
Case Study
The Science 37 Metasite in Action: Accelerating Enrollment for an Infectious Disease Trial.
The Science 37 Metasite in Action: Accelerating Enrollment for an Infectious Disease Trial.
A biopharma company was conducting a phase II randomized controlled trial for an infectious disease. The protocol required the participation of high-risk comorbidity patients ages 65+…
Read More
/Resources/science-37-metasite-action-accelerating-enrollment-infectious-disease-trial
Case Study
Science 37 Accelerates Timelines and Expands Reach in Infectious Disease Study.
Science 37 Accelerates Timelines and Expands Reach in Infectious Disease Study.
A biotech company approached Science 37 to swiftly recruit, enroll, and treat a targeted population of participants across the United States. The study was unique due to the challenge…
Read More
/Resources/science-37-accelerates-timelines-and-expands-reach-infectious-disease-study-0
Insight Brief
How to Save an At-Risk Clinical Trial
How to Save an At-Risk Clinical Trial
How can you rescue an at-risk clinical trial without compromising quality? Delays in clinical research are common and cost pharmaceutical companies exorbitant amounts of money. Four in…
Read More
/Resources/how-save-risk-clinical-trial
Blog
Include Virtual Sites in Your Infectious Disease Research
Top Five Reasons to Include Virtual Sites in Your Infectious Disease Research
Virtual sites can help deliver infectious disease studies more quickly, more inclusively and in a more patient-centric way.
Read Now
/top-five-reasons-include-virtual-sites-your-infectious-disease-research
Playbook
THE INFECTIOUS DISEASE CLINICAL TRIAL PLAYBOOK
How to Operationalize Infectious Disease Trials with a Virtual Site.
Download our Infectious Disease Clinical Trial Playbook to discover the premier, patient-centric strategy for solving hallmark challenges in infectious disease research. In this…
Learn More
/Resources/how-operationalize-infectious-disease-trials-virtual-site
Blog
European DCT Guidance
4 Things to Know about the EMA’s Updated Decentralized Clinical Trial Recommendations
Studies with Decentralized Clinical Trial (DCT) elements must be fit-for-purpose—and designed to protect patient safety, privacy and rights
Read More
/four-things-know-about-emas-updated-decentralized-clinical-trial-recommendations
Blog
The Adoption of Hybrid Oncology Trials Will Accelerate in 2023 and Beyond
Science 37 Forecast—The Adoption of Hybrid Oncology Trials Will Accelerate in 2023 and Beyond
Oncology is a therapeutic area of singular importance in clinical research. Breakthroughs in drug discovery will catalyze numerous studies for targeted cancer treatments, with Evaluate…
Read More
/science-37-forecast-adoption-hybrid-oncology-trials-will-accelerate-2023-and-beyond
Case Study
Science 37 Uses the Metasite to Support Clinical Trial in Rare Neurodegenerative Disease.
Science 37 Uses the Metasite to Support Clinical Trial in Rare Neurodegenerative Disease.
An industry leading pharmaceutical company implemented the Science 37’s Metasite to reduce patient patient burden and accelerate trial timelines. Learn how the Metasite expanded reach…
Read More
/Resources/science-37-uses-metasite-support-clinical-trial-rare-neurodegenerative-disease
Case Study
Science 37 Utilizes Flexibility of the Metasite Model in Study of Rare Disease.
Science 37 Utilizes Flexibility of the Metasite Model in Study of Rare Disease.
A biotech company approached Science 37 to develop a virtualized process to evaluate patients who may be eligible for an interventional study with a novel gene therapy program for a…
Read More
/Resources/science-37-utilizes-flexibility-metasite-model-study-rare-disease
Case Study
Science 37 Metasite Delivers Broad Patient Access in MDD Trial
Science 37 Metasite Delivers Broad Patient Access in MDD Trial
A global leader in pharmaceuticals was looking to pilot an interventional study in major depressive disorder (MDD) using a Metasite model, in parallel to their Phase IIb trial.   …
Read More
/Resources/science-37-metasite-delivers-broad-patient-access-mdd-trial
Infographic
Oncology Survey Infographic
Clinical decision makers confirm a shift to hybrid and decentralized studies.
Clinical research is undergoing transformation across the board—but how will it impact oncology clinical trials? Science 37® has surveyed research executives at trial-sponsored…
Read More
/Resources/clinical-decision-makers-confirm-shift-hybrid-and-decentralized-studies
Blog
What Clinical Trial Patient Participants Want
What Clinical Trial Patient Participants Want
A new groundbreaking research study reveals the perceptions and preferences of clinical trial participants and how those determinants impact all factors of the trial lifecycle. In her…
Read More
/what-clinical-trial-patient-participants-want
Poster
CNS Summit 2022 Depression Study poster
Evidence From Two Parallel Depression Trials
The adoption of the Decentralized Clinical Trial model in psychiatry has been tempered by concern regarding the conduct of clinician-reported outcomes conducted by centralized raters.…
Learn More
/Resources/evidence-two-parallel-depression-trials
Blog
Agile Clinical Trials 2022
Pharma Execs Prefer Hybrid Clinical Trials
Hybrid clinical trials continue to gain traction as stakeholders see the measurable benefits that remote study technology brings to clinical research. Read the latest blog from Drew…
Read More
/pharma-execs-prefer-hybrid-clinical-trials
Playbook
Operationalize Oncology Trials
How to Operationalize Oncology Trials with a Decentralized Approach
The importance of oncology in pharmaceutical research cannot be underestimated. However, oncology trials face challenges such as slow recruitment, complex protocols and frequent…
Read Now
/Resources/how-operationalize-oncology-trials-decentralized-approach
Case Study
Science 37 Accelerates Timelines and Expands Reach in Infectious Disease Study
Science 37 Accelerates Timelines and Expands Reach in Infectious Disease Study.
An industry-leading non profit institute was looking to execute a hybrid Phase II Randomized Controlled Study to determine the effectiveness of an interventional therapy. In this case…
Read now
/Resources/science-37-accelerates-timelines-and-expands-reach-infectious-disease-study
White Paper
Decentralized Clinical Trials — Is there a Positive Return on Investment on a Virtual Site?
Decentralized Clinical Trials — Is there a Positive Return on Investment on a Virtual Site?
Across the Life Sciences industry, there has been much talk about the cost and value of decentralized clinical trials (DCT) and the potential return on investment (ROI)  when the…
Read Now
/Resources/Modeling-Trial-Cost-and-Timelines-to-Maximize-Decentralized-Clinical-Trial-ROI
Case Study
Science 37 Accelerates Timelines and Expands Reach in Infectious Disease Study
Science 37 Accelerates Timelines and Expands Reach in Infectious Disease Study
An industry-leading non profit institute was looking to execute a hybrid Phase II Randomized Controlled Study to determine the effectiveness of an interventional therapy. In this case…
Read now
/Resources/science-37-accelerates-timelines-and-expands-reach-infectious-disease-study
ROI Calculator
Calculate your savings today! 
Calculate your Virtual Site ROI with a Science 37 Expert
Schedule time with a Science 37 expert and receive personalized results on how decentralized solutions can: Accelerate timelines Save opportunity costs Increase patient enrollment…
Learn More
/Resources/calculate-your-trial-savings-science-37-expert
Published Paper
Applied Clinical Trials
Evaluating the Use of Backup Solutions for ePRO Systems
A retrospective examination of the effectiveness, usability, and challenges with web-based electronic clinical outcome assessment (eCOA) backups.
Read More
https://www.appliedclinicaltrialsonline.com/view/evaluating-the-use-of-backup-solutions-for-epro-systems
Blog
Patient participating in clinical trial
A Long-Time Pharmaceutical Executive’s Experience Participating in a Clinical Trial
With 15 years of experience in pharmaceuticals, Science 37’s Leah Zilla thought she knew what to expect when she signed up for a traditional trial for a COVID-19 vaccine. Her…
Read Now
/long-time-pharmaceutical-executives-experience-participating-clinical-trial
Report
Patient accessing teleheatlh in a decentralized clinical trial
How Decentralized and Hybrid Trials are Impacting Clinical Research
Science 37’s 2nd Annual The Future of Clinical Trials Survey shares how the acceleration and adoption of decentralized clinical trials will reshape the research landscape in 2023.…
Read Now
/decentralized-clinical-trials-trends-report-2022
Blog
Lady accessing telehealth
Decentralized Clinical Trials—Where the Industry is Now.
The clear and hidden benefits of the hybrid and decentralized clinical trial models and how to implement agile trials to enhance clinical research.  
Read Now
/decentralized-clinical-trials-where-industry-now
White Paper
Diversity in Clinical Trials Whitepaper
How to Meet the FDA Diversity Action Plan Guidance
The pending FDA Guideline’s intention is clear—pharma companies must plan, report and collaborate to improve diverse representation in clinical trials. Most sponsors have assessed…
Read Now
/Resources/how-meet-fda-diversity-action-plan-guidance
Insight Brief
Patient accessing decentralized clinical trials
Why Migraine and Other Headache Disorders Are a Good Fit for Decentralized Clinical Trials
Characterized by recurring episodes of moderate to severe headache, elevated sensitivity to sound and/or light and other unpleasant symptoms, migraines can often be debilitating for…
Read Now
/Resources/why-migraine-headache-disorders-are-good-fit-decentralized-clinical-trials
Published Paper
Journal of Clinical Oncology
Decentralized Clinical Trials in Oncology: Are We Ready for a Virtual-First Paradigm?
 In this paper, published in the Journal of Clinical Oncology, Dr. Shaalan Beg MD MS and team explore how decentralized clinical trial tools are poised to impact the oncology clinical…
Read Now
https://ascopubs.org/doi/full/10.1200/JCO.22.00358
Blog
Decentralizing Clinical Research
Refining, Rethinking, and Decentralizing Clinical Research
Decentralized tools and technologies will continue to provide new opportunities for patient engagement post-COVID.
Read Now
/refining-rethinking-and-decentralizing-clinical-research
Video-on-Demand
Speakers at the Agile Approach to Decentralized Clinical Trials Webinar
A More Agile Approach to Decentralized Clinical Trials
Why a flexible, configurable, and dynamic approach to clinical trials is the post-pandemic solution for the most innovative sponsors.
Watch here
/agile-clinical-trial
Video-on-Demand
Speakers of the webinar
New Data on the Future of CNS Clinical Trials
In this special webinar event, Science 37 presented the results of a new study that looks at how future trends in clinical research will affect the CNS (central nervous system) space…
Watch Back
/Company/Events/webinar-new-data-future-cns-clinical-trials
Video-on-Demand
The Agile Trial: A New Clinical Leadership
The Agile Trial: A New Clinical Leadership
Traditional or decentralized–is it a binary decision? As the industry changes and evolves, we are continually asking what’s practical, what’s patient-centric, and what’s acceptable to…
Watch Back
/Company/Events/agile-trial-new-clinical-leadership
Video-on-Demand
Speakers at the "Disrupting the Clinical Trial: When to Decentralize?" Webinar
Disrupting the Clinical Trial: When to Decentralize?
Across industries, leaders examine disruptive innovation, looking at the inflection points that lead to broader adoption. The adoption phase in decentralization is now. Yes, there has…
Watch Back
/Company/Events/disrupting-clinical-trial-when-decentralize
Video-on-Demand
Oncology Clinical Trials: How Hybrid Approaches are Changing The Clinical Landscape
Oncology Clinical Trials: How Hybrid Approaches are Changing The Clinical Landscape
Earlier in 2022, Science 37® surveyed research executives at trial-sponsored organizations, uncovering pivotal insights on clinical research trends that are impacting the oncology…
Watch Back
/Company/Events/oncology-report-2022-video-on-demand
Blog
Using eCOA on a mobile device for a decentralized clinical trial
How Accelerating eCOA Implementation Benefits Decentralized Clinical Trials
A key benefit of decentralized clinical trials is the ability to enable faster trials, through improved patient recruitment, retention, and diversity. eCOA, when implemented correctly…
Read More
/how-accelerating-ecoa-implementation-benefits-decentralized-clinical-trials
White Paper
An Executive Clinical Trial Playbook
An Executive Clinical Trial Playbook
How Decentralized and Hybrid Clinical Trials Accelerate Research and Enable Diversity   While no longer a new concept, decentralized clinical trials can be challenging to comprehend…
Read Now
/clinicaltrialplaybook
Insight Brief
Decentralized Clinical Trial Technology— How to Accelerate eCOA Implementation
Decentralized Clinical Trial Technology— How to Accelerate eCOA Implementation
The key benefits of decentralized clinical trials is the ability to enable faster implementation of trials, greater speed to go live, and accelerated timelines.   Electronic clinical…
Learn More
/Resources/decentralized-clinical-trial-technology-how-accelerate-ecoa-implementation
Blog
Is Your Clinical Trial Technology Disconnected?
Is Your Clinical Trial Technology Disconnected?
How to improve patient, site, and sponsor/CRO experience through unified technology.
Read Now
https://www.science37.com/your-clinical-trial-technology-disconnected
Blog
Cancer Patients Prefer Decentralized Trials
Cancer Patients Prefer Decentralized Trials
A new industry survey shows oncology trials are embracing decentralized methods to keep patients safe, engaged, and committed.
Read now
/cancer-patients-prefer-decentralized-trials
Blog
Improving the Patient Journey & Increasing Equitable Access in Oncology Research
Improving the Patient Journey & Increasing Equitable Access in Oncology Research
Accurate representations of patient populations are critical to producing reliable clinical evidence for patient care.
Read now
/improving-patient-journey-increasing-equitable-access-oncology-research
Report
Download the Latest Oncology Research Report
How Decentralized Clinical Trials are Impacting Oncology Research
Clinical research is undergoing transformation across the board—but how will it impact oncology clinical trials? Science 37® has surveyed research executives at trial-sponsored…
Read Now
/Resources/how-decentralized-clinical-trials-are-impacting-oncology-research
Blog
A New Era of Accessible Clinical Trials. #ClinicalTrialsDay
A New Era of Accessible Clinical Trials
The original clinical trial laid the foundation for modern clinical studies. Thanks to the people working in clinical research, we have the opportunity to provide access to more people…
Read More
/new-era-accessible-clinical-trials
Poster
How Decentralized Clinical Trials Deliver on Diversity: A Case Study
How Decentralized Clinical Trials Deliver on Diversity: A Case Study
Agile studies and fully Decentralized Clinical Trials are opening opportunities for any patient anywhere to benefit from participation in clinical research. This can have impacts on…
Read now
/Resources/how-decentralized-clinical-trials-deliver-diversity-case-study
Blog
Building Inclusive Clinical Trials for the LGBTQIA+ Community
Building Inclusive Clinical Trials for the LGBTQIA+ Community
As we consider the strides made in awareness and visibility through Pride Month, we look at our own arena, healthcare, and see a much different picture.
Read Now
/building-inclusive-clinical-trials-strategies-include-lgbtqia-community
Insight Brief
Improve Long-Term Follow-Up Studies with DCT
Improve Long-Term Follow-Up Studies with Decentralized Clinical Trials
In his latest insight brief, Gordon Cummins shares how more agile and DCT approaches can optimize the delivery of long-term follow-up studies—improving and accelerating Real World…
Read now
/Resources/improve-long-term-follow-studies-dct
Blog
clinical trials day 2022
A New Era of Accessible Clinical Trials
On this Clinical Trials Day, we highlight the opportunity to provide access to more people in more places and thank the people working within clinical research to make it happen.
Read now
/new-era-accessible-clinical-trials
Blog
This International Nurses Day we elevate the voices of our mobile nursing team and share what inspires them most about their work in decentralized clinical trials.
Investing in our Mobile Nursing Network and Elevating our Nurses Voices.
This International Nurses Day we elevate the voices of our mobile nursing team and share what inspires them most about their work in decentralized clinical trials.
Read now
/investing-our-mobile-nursing-network-elevating-our-nurses-voices
Blog
New Diversity Reporting Imperatives For Clinical Trial Sponsors By Lawmakers & Regulators
New Diversity Reporting Imperatives For Clinical Trial Sponsors By Lawmakers & Regulators
The F.D.A. recommends that clinical trial sponsors develop a Race and Ethnicity Diversity Plan to inform outreach, recruitment and retention throughout the trial process.
Read now
/new-diversity-reporting-imperatives-clinical-trial-sponsors-lawmakers-regulators
Factsheet
Accelerate Enrollment and Enable Diversity with The Science 37 Metasite™
Accelerate Enrollment and Enable Diversity with The Science 37 Metasite™
Traditional clinical trials exclude more than 90 percent of patients and providers because of geographic and access barriers. This leads to study delays, excessive costs, and…
Read now
/Resources/accelerate-enrollment-and-enable-diversity-science-37-metasitetm
Factsheet
Mobile Nursing: A Global Mobile Healthcare Provider Network
Mobile Nursing: A Global Mobile Healthcare Network
The healthcare landscape has changed, and mobile healthcare is now an integral part of clinical research. Beyond nursing, mobile healthcare must deliver more – compassion,…
Read now
/Resources/mobile-nursing-global-mobile-healthcare-network
Insight Brief
We have the capability to reach anyone, anywhere utilizing decentralized clinical trial techniques and more agile clinical trial designs.
Decentralization: An Ethical Obligation
For more than 60 years, the traditional clinical trial model has relied on a disparate network of independent investigator sites to find, enroll, and matriculate patients through a…
Read now
/sites/default/files/2022-04/S37_InsightBrief_DecentralizationAnEthicalObligation_r3.pdf
Blog
Science 37 hosted a webinar, called The Agile Trial: A New Clinical Leadership, where experts from PWC, Boehringer Ingelheim, Regeneron and Impatient Health discussed the opportunities and challenges life sciences companies face in a future that will be defined by agile trial methodologies.
A New Clinical Leadership—The Agile Clinical Trial
To access the full advantage of decentralized trials, sponsors have to begin the planning process with agile in mind.
Read now
/new-clinical-leadership-agile-clinical-trial
Poster
For this Phase II study of an oral investigative compound, Science 37® embarked on a journey to design the first ever decentralized clinical trial (DCT) in depression.
Pioneering a First-Of-It’s-Kind Decentralized Clinical Trial in Depression.
There is a significant unmet medical need for patients with Major Depressive Disorder (MDD) who either do not respond to, or do not tolerate, current augmentation approaches for…
Read now
/Resources/pioneering-first-its-kind-decentralized-clinical-trial-depression
Poster
Combining Decentralized Clinical Trial Technology, Effective Mobile Nursing and Connected Devices To Deliver Pediatric Clinical Trials At Home
Benefits of DCT technology, mobile nursing and connected devices on pediatric clinical trials
At DIA Europe 2022, Senior Director of Nursing Solutions for Science 37, Brianne Peters presented a poster on Combining DCT Technology, Effective Mobile Nursing and Connected Devices…
Read now
/Resources/combining-dct-technology-effective-mobile-nursing-and-connected-devices-deliver-pediatric
Blog
With benefits such as faster enrollment, more comprehensive data, and the ability to recruit more diverse patient populations from anywhere in the world- CNS clinical trials are among the fastest-growing adopters of decentralized clinical trials
Enhancing CNS Studies with Agile and Decentralized Clinical Trials
CNS clinical trials are among the fastest-growing adopters of decentralization.
Read now
/enhancing-cns-studies-agile-and-decentralized-clinical-trials
Blog
Can the future of ending health disparities and improving health outcomes for Black Americans be in participation in clinical trials? What role does mental health play in current and future health outcomes? A panel of experts discuss.
Breaking Through Mistrust to Better Mental Health in Black Communities
What role does mental health play in current and future health outcomes? A panel of experts discuss.
Read now
/breaking-through-mistrust-better-mental-health-black-communities
Case Study
A global leader in pharmaceuticals was looking to pilot the same interventional study in major depressive disorder (MDD) using a decentralized clinical trial (DCT) model to evaluate operational feasibility, data quality, enrollment speed, and retention. Science 37 helped expand reach beyond the confines of traditional sites, reaching patients who otherwise were unable to access the trial. 
Decentralized Model Delivers in Major Depressive Disorder Clinical Trial
In parallel to their Phase IIb trial, a global leader in pharmaceuticals was looking to pilot the same interventional study in major depressive disorder (MDD) using a decentralized…
Read now
/Resources/decentralized-model-delivers-major-depressive-disorder-clinical-trial
Insight Brief
Clinical trials for rare diseases have always presented challenges. From investigator training to data collection, conducting clinical research for orphan disorders is mired with condition-specific challenges that slow development and place an enormous burden on patients wanting to participate in a potentially life-saving clinical trial.
Powering Rare Disease Research with Agile, Decentralized and Patient- Centric Approaches.
Through the rapidly increasing trend of agile, patient-centric approaches, we can address the distinctive challenges for patients with rare diseases. Travel may be difficult. Many are…
Read now
/Resources/powering-rare-disease-research-agile-decentralized-and-patient-centric-approaches-0
Factsheet
Clinical trials for rare diseases have always presented challenges. From investigator training to data collection, conducting clinical research for orphan disorders is mired with condition-specific challenges that slow development and place an enormous burden on patients wanting to participate in a potentially life-saving clinical trial.
Making Rare Disease Research Easier for Patients, Easier for Everyone
Through the rapidly increasing trend of patient-centric research, we can address the distinctive challenges for patients with rare diseases. Travel may be difficult. Many are children…
Read now
/Resources/making-rare-disease-research-easier-patients-easier-everyone
Report
How will decentralization impact CNS (central nervous system) clinical trials? Science 37 has surveyed research executives at trial-sponsoring organizations, uncovering pivotal insights on how clinical research trends are impacting the CNS space.
How Agile Clinical Trials are Impacting CNS Research
We know that clinical research is undergoing transformation across the board—but how will it impact CNS (central nervous system) clinical trials? Science 37® has surveyed research…
Read now
/Resources/how-agile-clinical-trials-are-impacting-cns-research
Blog
Powering Rare Disease Research with Agile, Decentralized and Patient-Centric Approaches
Powering Rare Disease Research with Agile, Decentralized and Patient-Centric Approaches
Here are key takeaways from a recent Science 37-hosted rare disease-focused webinar:
Read now
/powering-rare-disease-research-agile-decentralized-and-patient-centric-approaches
Insight Brief
In this new insight brief, Science 37 CEO David Coman explains how agile and decentralized approaches actually offer sponsors more centralized command and oversight compared to traditional study design.
Centralize Clinical Trials with Decentralized Clinical Trials.
As the industry adopts more agile and decentralized approaches, it has rallied around the term decentralized clinical trials and expanded its definition to include all mobile, remote,…
Read now
/sites/default/files/2022-05/Decentralized_Clinical_Trials_Insight_Brief_d01.pdf
The DEPICT Act - new US legislation aimed at boosting diversity in clinical trials
The DEPICT Act
Are you prepared for the DEPICT Act? The industry is making significant headway in delivering diversity in clinical trials, and the time to do more is now. 

On February 3, 2022, Rep…
Read now
/Resources/depict-act
Blog
Learn More
Motivated by the Urgency for a Better Way: Researcher, Joannie Hayes’s Background Fuels Her Work and Reflection on Black History Month
Read now
/motivated-urgency-better-way-researcher-joannie-hayess-background-fuels-her-work-and-reflection
Blog
As a child Nortorious thought she wanted to be a doctor. While in school, however, she uncovered her true passion—research—studying science to help prevent people from avoiding poor health. Her heart as a researcher fuels her perspective about Black History Month and the importance of studying and honoring those who came before us as we work toward a better future.
The Heart of a Researcher: Science-Centered Nortorious Coleman-Taylor Highlights the Importance of Black History Month
Read now
/heart-researcher-science-centered-nortorious-coleman-taylor-highlights-importance-black-history
Blog
learn more about reshaping trials in 2022, click here to download our latest report
Reshaping Clinical Trials in 2022
Read now
/reshaping-clinical-trials-2022
Blog
Privacy By Design Protects Clinical Trial Participants
Privacy By Design Protects Clinical Trial Participants
Happy Data Privacy Day!  But, really, isn’t every day privacy day?  As Science 37’s Privacy Officer, I certainly take that approach. Protecting the privacy rights and freedoms of…
Read now
/privacy-design-protects-clinical-trial-participants
Blog
How Access to the HPV Vaccination is helping to Eliminate Cervical Cancer
How Access to the HPV Vaccination is helping to Eliminate Cervical Cancer
With the arrival of Cervical Health Awareness Month, comes news out of the U.K. that The human papillomavirus, or HPV, the vaccine is cutting cases of cervical cancer by nearly 90%.
Read now
/how-access-hpv-vaccination-helping-eliminate-cervical-cancer
Blog
S37
Working with Native Americans to Navigate the COVID-19 Crisis
This Native American Heritage Month, we take a look at how the COVID-19 crisis has highlighted long standing inequities, as well as the fight to overcome them.
Read now
/Resources/Working-with-Native-Americans-to-Navigate
Case Study
Enabling Diversity in Cancer Screening Study
Enabling Diversity in Cancer Screening Study
We take a bespoke approach to all our trials. We understand every therapeutic area is different. We performed a careful review of trial design, inclusion/exclusion criteria, and review…
Read now
/Resources/enabling-diversity-cancer-screening-study
Case Study
This case study highlights the success we had in providing a flexible approach in a COVID19 study, to a non-for-profit sponsor, to quickly access a more representative patient population.
Ensuring Diversity in a COVID-19 study
We take a bespoke approach to all our trials. We understand every therapeutic area is different. We perform careful review of trial design, inclusion/exclusion criteria, and review of…
Read now
/Resources/ensuring-diversity-covid-19-study
Report
The Decentralized Clinical Trial Operating System
The Decentralized Clinical Trial Operating System
A requisite, technology-first platform with limitless configurations to enable clinical research.
Read now
/DCT-OS-Report
White Paper
Clinical Research in the COVID-19 Era: Methods for Continuity
Clinical Research in the COVID-19 Era: Methods for Continuity
Adjust ongoing trials and have the changes expeditiously reviewed by an accredited IRB.
Read now
/Covid-19
Factsheet
Empowering Diversity in Clinical Trials
Empowering Diversity in Clinical Trials
Diverse audiences want to participate in clinical trials but so often, are not asked, overlooked, or unable to access because of geographic barriers.  The Diversity in Clinical Trials…
Read now
/Resources/empowering-diversity-clinical-trials
White Paper
Navigating Clinical Trials in the Coronavirus Era
Navigating Clinical Trials in the Coronavirus Era
Explore approaches to mitigate risks to patient safety in ongoing clinical trials.
Read now
/Covid-19

Providers

Connect with a Science 37 Solutions Expert Today To Learn More About How We Can Help You.

Contact us today to learn more